These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15850845)

  • 1. The metabolic syndrome and cardiovascular risk in Cushing's syndrome.
    Pivonello R; Faggiano A; Lombardi G; Colao A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):327-39, viii. PubMed ID: 15850845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing's disease from metabolic syndrome.
    Setola E; Losa M; Lanzi R; Lucotti P; Monti LD; Castrignanò T; Galluccio E; Giovanelli M; Piatti P
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):586-92. PubMed ID: 17371479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease in Cushing's syndrome: heart versus vasculature.
    De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure.
    Pecori Giraldi F; Toja PM; De Martin M; Maronati A; Scacchi M; Omboni S; Cavagnini F; Parati G
    Horm Metab Res; 2007 Dec; 39(12):908-14. PubMed ID: 18046661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
    Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines and cardiovascular risk in Cushing's syndrome.
    Valassi E; Biller BM; Klibanski A; Misra M
    Neuroendocrinology; 2012; 95(3):187-206. PubMed ID: 22057123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.
    Webb SM; Mo D; Lamberts SW; Melmed S; Cavagnini F; Pecori Giraldi F; Strasburger CJ; Zimmermann AG; Woodmansee WW;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):630-8. PubMed ID: 20022992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.
    Zarich SW
    Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk factor association syndrome as a barisystemic syndrome: a view on obesity and the metabolic syndrome.
    Nunes JP
    Med Hypotheses; 2007; 68(3):541-5. PubMed ID: 17029803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
    Müller A; Mulhall JP
    Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease.
    Pecori Giraldi F; Scaroni C; Arvat E; Martin M; Giordano R; Albiger N; Leao AA; Picu A; Mantero F; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):219-24. PubMed ID: 16430724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.